CD55 antibody (AA 51-150)
-
- Target See all CD55 Antibodies
- CD55 (Complement Decay-Accelerating Factor (CD55))
-
Binding Specificity
- AA 51-150
-
Reactivity
- Human
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- This CD55 antibody is un-conjugated
-
Application
- Western Blotting (WB)
- Predicted Reactivity
- Human
- Immunogen
- KLH conjugated synthetic peptide derived from human CD55
- Clone
- D5FF2
- Isotype
- IgG1
- Top Product
- Discover our top product CD55 Primary Antibody
-
-
- Application Notes
- WB 1:300-5000
- Restrictions
- For Research Use only
-
- Concentration
- 0.5 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Preservative
- ProClin
- Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- 4 °C,-20 °C
- Storage Comment
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Expiry Date
- 12 months
-
- Target
- CD55 (Complement Decay-Accelerating Factor (CD55))
- Alternative Name
- CD55 (CD55 Products)
- Background
-
Synonyms: CD 55, CD55 antigen, CD55 Cromer blood group system, CD55 Molecule, CD55 Molecule, decay accelerating factor for complement (Cromer blood group), Cd55a, Complement decay accelerating factor, Complement decay-accelerating factor, Complement decay-accelerating factor, GPI-anchored, CR, CROM, Cromer Blood Group antigen, Cromer blood group system, DAF, Daf-GPI, DAF_HUMAN, Daf1, Dcay accelerating factor for complement (CD55, Cromer blood group system), Decay accelarating factor 1, isoform CRA_a, Decay accelerating factor (GPI-form), Decay Accelerating Factor for Complement, Decay accelerating factor GPI-form, Decay accelerating factor soluble-form, GPI-DAF, TC.
Background: This protein recognizes C4b and C3b fragments that condense with cell-surface hydroxyl or amino groups when nascent C4b and C3b are locally generated during C4 and c3 activation. Interaction of daf with cell-associated C4b and C3b polypeptides interferes with their ability to catalyze the conversion of C2 and factor B to enzymatically active C2a and Bb and thereby prevents the formation of C4b2a and C3bBb, the amplification convertases of the complement cascade.
- Gene ID
- 1604
- UniProt
- P08174
- Pathways
- Complement System, Regulation of Leukocyte Mediated Immunity
-